MEDVi vs Ro: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Ro overall, scoring 7.7/10 vs 7.2/10. Ro is more affordable at $149/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Ro for users who want fda-approved brand-name glp-1 access includin.
A side-by-side look at MEDVi and Ro to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#20 of 52MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDViRo
#43 of 52One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Ro| Feature | MEDVi | Ro |
|---|---|---|
| Our Score | 7.7/10 | 7.2/10 |
| Starting Price | $179/mo | $149/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Ranking | #20 | #43 |
| Get started | Visit MEDVi | Visit Ro |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
Ro
Pros
- +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-299/mo via LillyDirect matching
- +Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
- −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Our Verdict
MEDVi edges out Ro with a score of 7.7/10 vs 7.2/10. If budget is your priority, Ro starts at $149/mo compared to MEDVi's $179/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.
Still undecided? Editor's Featured Pick
Yucca Health
$146/mo · 7.7/10 · Compounded
If neither MEDVi nor Ro feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing MEDVi or Ro tend to look at next.
- MEDVi vs Shed$199/mo
- MEDVi vs Hers$199/mo
- MEDVi vs Henry Meds$199/mo
- Ro vs Found$129/mo
- Ro vs GoodRx Care$119/mo
- Ro vs Fella Health$299/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.